Use of vonoprazan for management of systemic sclerosis‑related gastroesophageal reflux disease-Reference-Cited by-同舟云学术

Use of vonoprazan for management of systemic sclerosis‑related gastroesophageal reflux disease

Published:2020-12-17 Issue:2 Volume:14 Page:
ISSN:2049-9434
Container-title:Biomedical Reports
language:
Short-container-title:Biomed Rep

Author:

Tabuchi Maiko¹^ORCID,Minami Hitomi¹,Akazawa Yuko¹,Ashida Miwa²,Hara Toshihide³,Ichinose Kunihiro⁴,Kitayama Moto¹,Hashiguchi Keiichi¹,Matsushima Kayoko¹,Yamaguchi Naoyuki¹,Takeshima Fuminao¹,Kondo Hisayoshi⁵,Kawakami Atsushi⁴,Nakao Kazuhiko¹

Affiliation:

1. Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Science, Nagasaki 852‑8501, Japan

2. Department of Dermatology, Nagasaki University Graduate School of Biomedical Science, Nagasaki 852‑8501, Japan

3. Department of Dermatology, Japan Community Healthcare Organization, Isahaya General Hospital, Isahaya, Nagasaki 854‑8501, Japan

4. Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Science, Nagasaki 852‑8501, Japan

5. Division of Scientific Data Registry, Atomic Bomb Disease and Hibakusya Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki 852‑8523, Japan

Publisher

Spandidos Publications

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Managing gastrointestinal manifestations in systemic sclerosis, a mechanistic approach;Expert Review of Clinical Immunology;2024-02-26

2. Prevalence and risk factors for medication-refractory reflux esophagitis in patients with systemic sclerosis in Japan;Journal of Gastroenterology;2024-01-22

3. Atteinte digestive de la sclérodermie systémique;La Revue de Médecine Interne;2023-08

4. Gastrointestinal Tract Considerations Part I;Rheumatic Disease Clinics of North America;2023-05

5. Proton pump inhibitors in systemic sclerosis: a reappraisal to optimise treatment of gastro-oesophageal reflux disease;The Lancet Rheumatology;2022-11